LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • Wedbush Is Cutting Spyre Therapeutics, Inc. (SYRE) Q3 26 Estimate To -0.80 From -0.24 2/20/2026 6:36:38 AM
  • Wedbush Is Cutting Spyre Therapeutics, Inc. (SYRE) Q2 26 Estimate To -0.79 From -0.21 2/20/2026 6:36:24 AM
  • Wedbush Is Cutting Spyre Therapeutics, Inc. (SYRE) Q1 26 Estimate To -0.76 From -0.18 2/20/2026 6:36:09 AM
  • Wedbush Reiterates Spyre Therapeutics, Inc. (SYRE) At Outperform With $65 Price Target 2/20/2026 6:34:24 AM
  • Spyre Therapeutics Prices $275 Mln Public Offering To Advance IBD Pipeline 10/13/2025 9:28:15 PM
  • Spyre Therapeutics Showcases Promising SPY002 And Combination Therapy Data At UEGW Congress 10/5/2025 9:04:44 AM
  • Wedbush Is Raising Spyre Therapeutics, Inc. (SYRE) FY26 Estimate To -2.49 From -2.60 8/6/2025 10:11:37 AM
  • Wedbush Is Raising Spyre Therapeutics, Inc. (SYRE) Q4 26 Estimate To -0.64 From -0.68 8/6/2025 10:11:26 AM
  • Wedbush Is Raising Spyre Therapeutics, Inc. (SYRE) Q3 26 Estimate To -0.61 From -0.65 8/6/2025 10:11:12 AM
  • Wedbush Is Increasing Spyre Therapeutics, Inc. (SYRE) Q2 26 Estimate To -0.60 From -0.63 8/6/2025 10:10:06 AM
  • Wedbush Is Lowering Spyre Therapeutics, Inc. (SYRE) Q1 26 Estimate To -0.64 From -0.63 8/6/2025 10:08:37 AM
  • Wedbush Is Raising Spyre Therapeutics, Inc. (SYRE) FY25 Estimate To -2.30 From -2.43 8/6/2025 10:08:18 AM
  • Wedbush Is Lowering Spyre Therapeutics, Inc. (SYRE) Q4 25 Estimate To -0.61 From -0.60 8/6/2025 10:08:05 AM